AF
Therapeutic Areas
Vaccinex Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Pepinemab (VX15/2503) | Huntington's Disease | Phase 2 |
Leadership Team at Vaccinex
MZ
Maurice Zauderer
Founder, President, Chief Executive Officer, and Chairman of the Board
EE
Elizabeth E. Evans
Chief Scientific Officer
MJ
Michael J. Molyneaux
Chief Financial Officer
JF
James F. Burns
Chief Legal Officer and Corporate Secretary
SR
Scott Royer
Member of the Board of Directors
RG
Robert G. Urban
Member of the Board of Directors
RE
Raymond E. Watkins
Member of the Board of Directors